← Evidence map

ArticleBlood advances2025

Evaluating the long-term benefits of hydroxyurea in pediatric sickle cell anemia.

Paul George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40238672